Literature DB >> 26077949

Minimally invasive follicular carcinoma: predictors of vascular invasion and impact on patterns of care.

Paolo Goffredo1, Christa Jillard2, Samantha Thomas3, Randall P Scheri2, Julie Ann Sosa1,2, Sanziana Roman4.   

Abstract

Some studies have reported that minimally invasive follicular carcinoma (MIFC) with vascular invasion is associated with compromised prognosis, leading to an ongoing debate regarding extent of surgery for MIFC. Our goal was to identify predictors of vascular invasion and determine its impact on patterns of care. Adult patients with MIFC were culled from the National Cancer Database, 2010-2011, and segregated according to the presence/absence of capsular or vascular invasion. Variables of interest were examined using Chi-square and student's t tests. Multivariate analysis was performed with logistic regression. A total of 617 patients with MIFC were identified: 54% with capsular invasion only and 46% with vascular invasion. Demographic characteristics were similarly distributed between the two groups. Tumor size was larger in patients with vascular invasion (mean = 35.7 vs. 29.2 mm capsular invasion only, p < 0.001); a 2% increase in risk of vascular invasion was observed with each 1 mm increase in size. The rate of total thyroidectomy was similar for MIFCs with vascular invasion compared to capsular invasion only (72.9 vs. 75.1%, p = 0.537). The RAI administration rate was higher in patients with vascular invasion (62.1 vs. 52.6% capsular invasion only, p = 0.017). In multivariate analysis, the presence of vascular invasion was independently associated with increased likelihood of receiving RAI (OR 1.641, p = 0.007). MIFC remains aggressively treated despite current guidelines favoring a more conservative approach. Building consensus around MIFC management is important for standardization of practice patterns and improvement in quality of care.

Entities:  

Keywords:  Minimally invasive follicular carcinoma; RAI; Surgery; Thyroid

Mesh:

Substances:

Year:  2015        PMID: 26077949     DOI: 10.1007/s12020-015-0649-z

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  24 in total

Review 1.  Follicular-patterned lesions of the thyroid: the bane of the pathologist.

Authors:  Zubair W Baloch; Virginia A Livolsi
Journal:  Am J Clin Pathol       Date:  2002-01       Impact factor: 2.493

2.  Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer.

Authors:  David S Cooper; Gerard M Doherty; Bryan R Haugen; Bryan R Hauger; Richard T Kloos; Stephanie L Lee; Susan J Mandel; Ernest L Mazzaferri; Bryan McIver; Furio Pacini; Martin Schlumberger; Steven I Sherman; David L Steward; R Michael Tuttle
Journal:  Thyroid       Date:  2009-11       Impact factor: 6.568

3.  Association of vascular invasion with increased mortality in patients with minimally invasive follicular thyroid carcinoma but not widely invasive follicular thyroid carcinoma.

Authors:  Hye Jeong Kim; Ji-Youn Sung; Young Lyun Oh; Jung Han Kim; Young-Ik Son; Yong-Ki Min; Sun Wook Kim; Jae Hoon Chung
Journal:  Head Neck       Date:  2014-02-27       Impact factor: 3.147

4.  Management of follicular thyroid carcinoma should be individualised based on degree of capsular and vascular invasion.

Authors:  C J O'Neill; L Vaughan; D L Learoyd; S B Sidhu; L W Delbridge; M S Sywak
Journal:  Eur J Surg Oncol       Date:  2010-12-08       Impact factor: 4.424

5.  Does completion thyroidectomy improve the outcome of patients with minimally invasive follicular carcinoma of the thyroid?

Authors:  Kiminori Sugino; Kaori Kameyama; Mitsuji Nagahama; Wataru Kitagawa; Hiroshi Shibuya; Keiko Ohkuwa; Takashi Uruno; Junko Akaishi; Akifumi Suzuki; Chie Masaki; Ken-Ichi Matsuzu; Michikazu Kawano; Koichi Ito
Journal:  Ann Surg Oncol       Date:  2014-04-26       Impact factor: 5.344

6.  Prognostic factors of minimally invasive follicular thyroid carcinoma: extensive vascular invasion significantly affects patient prognosis.

Authors:  Yasuhiro Ito; Mitsuyoshi Hirokawa; Hiroo Masuoka; Tomonori Yabuta; Minoru Kihara; Takuya Higashiyama; Yuuki Takamura; Kaoru Kobayashi; Akihiro Miya; Akira Miyauchi
Journal:  Endocr J       Date:  2013-01-18       Impact factor: 2.349

Review 7.  Follicular-patterned afflictions of the thyroid gland: reappraisal of the most discussed entity in endocrine pathology.

Authors:  Zubair W Baloch; Virginia A LiVolsi
Journal:  Endocr Pathol       Date:  2014-03       Impact factor: 3.943

8.  The national cancer data base: past, present, and future.

Authors:  David P Winchester; Andrew K Stewart; Jerri Linn Phillips; Elizabeth E Ward
Journal:  Ann Surg Oncol       Date:  2009-10-22       Impact factor: 5.344

Review 9.  Update to the College of American Pathologists reporting on thyroid carcinomas.

Authors:  Ronald Ghossein
Journal:  Head Neck Pathol       Date:  2009-02-28

10.  Follicular thyroid carcinoma: histology and prognosis.

Authors:  Alessandra D'Avanzo; Patrick Treseler; Philip H G Ituarte; Mariwil Wong; Leanne Streja; Francis S Greenspan; Allan E Siperstein; Quan-Yang Duh; Orlo H Clark
Journal:  Cancer       Date:  2004-03-15       Impact factor: 6.860

View more
  4 in total

1.  The total number of tissue blocks per centimetre of tumor significantly correlated with the risk of distant metastasis in patients with minimally invasive follicular thyroid carcinoma.

Authors:  Brian Hung-Hin Lang; Tony W H Shek; Arnold L H Wu; Koon Yat Wan
Journal:  Endocrine       Date:  2016-12-07       Impact factor: 3.633

2.  CIRCULATING TUMOR CELLS IN MINIMALLY INVASIVE FOLLICULAR THYROID CARCINOMA AND BENIGN THYROID TUMORS WITH A FOLLICULAR PATTERN: PILOT EXPERIENCE.

Authors:  C I Badulescu; R J Marlowe; A Piciu; R Buiga; O Barbos; N I Bejinariu; G Chereches; E Barbus; E A Bonci; D Piciu
Journal:  Acta Endocrinol (Buchar)       Date:  2018 Jan-Mar       Impact factor: 0.877

3.  Minimally invasive follicular thyroid carcinomas: prognostic factors.

Authors:  Gustav Stenson; Inga-Lena Nilsson; Ninni Mu; Catharina Larsson; Catharina Ihre Lundgren; C Christofer Juhlin; Anders Höög; Jan Zedenius
Journal:  Endocrine       Date:  2016-02-08       Impact factor: 3.633

Review 4.  Hürthle cell carcinoma: current perspectives.

Authors:  Sara Ahmadi; Michael Stang; Xiaoyin Sara Jiang; Julie Ann Sosa
Journal:  Onco Targets Ther       Date:  2016-11-07       Impact factor: 4.147

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.